Close

Analyst Ratings for AbCellera Biologics (ABCL) [Buys]

ABCL Rating Summary

ABCL Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ABCL
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $19.83 (+292.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 96%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/22/2024 Benchmark Robert Wasserman Upgrade Buy
(Hold)
N/A
(N/A)
4.81
(5.05)
4.99% Details
12/5/2023 KeyBanc
» Updated 1/5/2024
Scott Schoenhaus New Coverage Overweight
(N/A)
8.00
(6.00)
4.83
(5.05)
4.55% Details
Like ABCL Ratings? Also take a look at REGN, INCY, PRLD

ABCL Ratings News